PEG-Loxe improves weight loss and glycemic control in super-obese T2DM patients
Polyethylene glycol loxenatide (PEG-Loxe) for weight reduction and metabolic improvement in super-obese patients with type 2 diabetes.
Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
Polyethylene glycol loxenatide (PEG-Loxe) for weight reduction and metabolic improvement in super-obese patients with type 2 diabetes.
This study evaluated the self-transcendence nursing model's effectiveness in managing gestational diabetes mellitus (GDM) patients compared to routine nursing care.
This study evaluated the effect of chewing gum on glycemic control in women with gestational diabetes mellitus. The gum-chewing group showed lower fasting and postprandial blood glucose levels compared to the control group.
This study evaluated a family-based health promotion intervention aimed at reducing T2DM risk factors among women with recent GDM. It found significant reductions in 2-hour insulin levels, triglycerides, and odds of elevated fasting plasma glucose.
This study explored the impact of the eMOM mobile app on maternal self-discovery and management of gestational diabetes, finding no significant differences in key outcomes.
This study evaluated the impact of Digital Twin technology on personalized nutrition for managing Type 2 Diabetes, showing potential improvements in various health markers.
This pilot study investigated the effect of brown seaweed on glucose regulation in patients with type 2 diabetes, finding no significant differences in key outcomes.
The INTERFAST-2 study evaluated the effects of intermittent fasting on individuals with insulin-treated type 2 diabetes, finding significant improvements in glycemic control and weight loss.
This study investigated the effects of time-restricted eating on mitochondrial bioenergetics in individuals at high risk of type 2 diabetes, finding no significant differences.
This study investigated the impact of marine n-3 fatty acid supplementation on carotid plaque risk in patients with type 2 diabetes and found no significant reduction in plaque prevalence or incidence.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.